Insider Cluster (2 insiders) ·Filed Sep 22, 2026
Insider cluster: 2 insiders, $295K total
Actionable Insight • Neutral
Sales are small and lack a clear informational signal. Monitor next insider filing for any change in pattern, particularly if C-suite executives begin selling larger positions.
Latest settled — T+20d
MLYS ▼ -21.53% at T+20d
NEUTRAL call -21.53% · α vs SPY -22.22% · entry $26.89 → $21.10
Latest observation: T+22 -27.10% FF3 residual α
T+1d
-1.12%
call -1.12% · α -1.03%
$26.59
settled 5w ago
T+5d
-6.55%
call -6.55% · α -5.87%
$25.13
settled 27d ago
T+20d
-21.53%
call -21.53% · α -22.22%
$21.10
settled 6d ago
T+60d
Pending
in 7w
Price Chart
Loading chart...
Executive Summary
Two insiders at Mineralys Therapeutics sold a combined $295K in open-market transactions over a week. The sales are modest relative to the company's market cap and likely reflect routine portfolio diversification rather than a negative signal.
Key Financial Metrics
Direction
selling
Total Value
$295.0K
Insiders
2
Key Facts
- Director Karydas Daphne sold 3,000 shares for $86K on 2026-09-15.
- Chief Commercial Officer Warren Eric sold 7,400 shares for $209K on 2026-09-21.
- Total insider sales of $295K represent a trivial fraction of market cap (likely <0.1%).
- No open-market purchases were reported in the cluster.
Financial Impact
$295K in total insider sales, immaterial relative to company size
insider ownership
Risk Factors
- Insider sales could accelerate if upcoming clinical data disappoints.
- No purchases to offset selling signal, though dollar amounts are too small to be meaningful.
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MLYS-1790117369519 |
30 reports for MLYS
57% Hit rate @ T+20 Went positive at some point 5 of 7 best @ T+20▲ +20.97%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 5d ago | 3 | $21.10 | awaiting T+20 | — | $20.45 (−3.08%) |
Oct 20, 2026 5d ago | 3 | $21.10 | awaiting T+20 | — | $20.45 (−3.08%) |
Oct 19, 2026 6d ago | 8-K | $21.58 | awaiting T+20 | — | $20.45 (−5.24%) |
Oct 13, 2026 12d ago | 144 | $20.76 | awaiting T+20 | — | $20.45 (−1.49%) |
Sep 30, 2026 25d ago | 144 | $23.72 | awaiting T+20 | — | $20.45 (−13.79%) |
Sep 29, 2026 26d ago | Press Release | $25.13 | awaiting T+20 | — | $20.45 (−18.62%) |
Sep 24, 2026 4w ago | Insider Cluster | $25.86 $20.55 | ▲ +20.53% | ▲ +19.06% | $20.45 (+20.92%) |
Sep 22, 2026 4w ago | Insider Cluster | $26.89 $21.10 | ▼ −21.53% | ▼ −22.22% | $20.45 (−23.95%) |
Aug 12, 2026 10w ago | 3 | $26.09 $28.20 | ▲ +8.09% | ▲ +9.83% | $20.45 (−21.62%) |
Jul 23, 2026 13w ago | Insider Cluster | $26.71 $25.65 | ▼ −3.97% | ▼ −7.59% | $20.45 (−23.44%) |
Showing 10 of 30
US Market Status
Market Open — Closes in 2h 56m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers